Advertisement
Screener

Monopar Therapeutics Inc. (MNPR) Deferred Tax Assets, Goodwill and Intangible Assets

2.8 / 5 stars · 68/120 Roast Me

Monopar Therapeutics Inc. Deferred Tax Assets, Goodwill and Intangible Assets

Monopar Therapeutics Inc. (MNPR) had Deferred Tax Assets, Goodwill and Intangible Assets of $8.77 million as of 2025-12-31, per its 10-K filed 2026-03-27.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2026-03-27

  • 2025-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $8.77M.
  • 2024-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $7.40M.
  • 2023-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $4.42M.
  • 2022-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $3.82M.
Period endDeferred Tax Assets, Goodwill and Intangible Assets
2025-12-31$8.77M
10-K · filed 2026-03-27
2024-12-31$7.40M
10-K · filed 2026-03-27
2023-12-31$4.42M
10-K · filed 2025-03-31
2022-12-31$3.82M
10-K · filed 2024-03-28
2021-12-31$3.15M
10-K · filed 2023-03-23
2020-12-31$2.43M
10-K · filed 2022-03-24
2019-12-31$1.44M
10-K · filed 2021-03-25
2018-12-31$1.05M
10-K · filed 2020-03-27
2017-12-31$730.65K
10-K · filed 2019-02-26
2016-12-31$419.54K
10-K · filed 2018-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
Altimmune, Inc. (ALT)United States$0.593B-6.43
CorMedix Inc. (CRMD)United States$0.605B3.25
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
Neurogene Inc. (NGNE)$0.625B-4.46
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
Indaptus Therapeutics, Inc. (INDP)United States$0.537B